Interest in the area of cerebral palsy (CP) and electrical stimulation continues to grow because it has potential as a passive, non-invasive, home-based therapy, which is claimed to result in gains in strength and motor function. 1, 2, 3, 4 If proved effective it might provide an alternative to resistive exercise techniques for children with poor selective muscle control, or indeed it might improve treatment compliance in those children who find exercise programmes difficult. Unfortunately, early reports on the efficacy of this intervention are undermined by poor methodology. A lack of consensus on optimal treatment parameters and variation in the physical abilities of the participants further confound interpretation of the literature.
Essentially, two variations of electrical stimulation are used in muscle strengthening in children with CP: neuromuscular electrical stimulation (NMES) and threshold electrical stimulation (TES). Under the Clinical Electrophysiology Section of the American Physical Therapy Association classification, both types of stimulation are classified as alternating current. 5 NMES is the application of an electrical current of sufficient intensity to elicit muscle contraction. To elicit a contraction, two electrodes are placed on the skin overlying the target musculature. Contraction occurs through the stimulation of the intramuscular branches of the nerve supplying the muscle. Two strengthening mechanisms are proposed: first, the overload principle, resulting in greater muscle strength by increasing the cross-sectional area of the muscle, and second, selective recruitment of type II fibres (fast twitch, large diameter fibres), causing improved synaptic efficiency of the muscle. 6 Stimulation can be provided regardless of the nature of the activity that the patient is participating in. However, when applied in a taskspecific manner, in which a muscle is stimulated when it should be contracting during a functional activity, the stimulation is referred to as functional electrical stimulation (FES). In this review FES will be taken to fall under the heading NMES. Dubowitz et al. 7 published the first report on the use of NMES for muscle strengthening in children with CP. Since then several studies of varying methodological rigour and quality have been published.
Alternatively, TES has been described as a low-level, subcontraction electrical stimulus applied at home during sleep. 8 Pape et al., who first published its potential use, 9 subsequently proposed that increased blood flow during a time of heightened trophic hormone secretion could result in increased muscle bulk. 8 Since then, several conflicting reports on its efficacy have been published.
The following review seeks to examine the quality and results of the research, specifically addressing the efficacy of electrical stimulation in strengthening or improving the motor function of children with CP. The stimulation types and parameters employed will also be discussed.
Method
A search was conducted for articles, written in English, on the use of electrical stimulation to strengthen muscles or improve motor function in children with CP. The MEDLINE (1966 ( to October 2003 , CINAHL (1982 to October 2003 , AMED (1985 to October 2003 , and PEDro (1966 to October 2003) databases were searched with the terms 'electrical stimulation' and 'cerebral palsy'. Further literature was obtained by exploring the reference lists of papers identified in this search. Articles were excluded if they were letters, review articles, commentaries or abstracts, if electrical stimulation was not the primary intervention, if the participants were not diagnosed with CP, or if the intervention was not primarily used to improve strength or motor performance. An exception was made for Dubowitz et al. 7 (as it was the first reported case of the use of electrical stimulation for strengthening that used objective outcome measures), in which a case series is described in a letter. This yielded a total of 18 articles: six randomized controlled trials, four uncontrolled/cohort studies, and eight case studies. Twelve of these studies looked at NMES intervention and six at the effects of TES.
The research methods employed to investigate the Common sense/first principles effects of electrical stimulation in children with CP vary widely, so it was necessary to evaluate the strength of the studies to determine the degree of confidence that one can place in their findings. The American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) adapted the work of Sackett 10 to produce a grading system that permitted the inclusion of less rigorous study design types 11 (see Table I ). This was deemed necessary within the field of developmental medicine because of the prevalence of smaller group studies and case reports. This adapted grading system is the method used by the Treatment Outcomes Committee in their evidence reports. 12, 13, 14, 15 The AACPDM further rated studies as strong (S), moderate (M) or weak (W), depending on the methodological quality of the study and how rigorously the study design had been followed. 11 Thus a randomized controlled trial with some methodological flaws (such as inappropriate choice of outcome measures and statistical methods, or no masking of assessors) would have a rating of level I/W, whereas a singleparticipant ABA design that was performed well would have a rating of level III/S. Level V studies are not rated for quality because they do not provide empirical research.
Three assessors independently reviewed each of the 18 articles using the criteria of the AACPDM classification of levels of evidence of internal validity. 11 Total agreement on the level of evidence occurred in 15 of 18 articles. The remaining 3 of 18 studies were discussed further in a group and a consensus on the appropriate level was reached. The quality ratings assigned to each study were also scored independently by each assessor and finalized by group discussion. Table II summarizes the design, methods and results of the six studies classified as level I evidence. By definition, these were all randomized controlled trials, three of which looked at the effects of NMES 1, 16, 17 and three examined TES. 18, 19, 20 None of the reviewed studies were level II evidence. The studies varied somewhat in terms of participant characteristics and study design. Participant numbers varied from 12 19 to 57, 20 with participants ranging in age from 8 months to 15 years and having diagnoses of hemiplegia, diplegia, or quadriplegia. Park et al. 16 looked at a much younger patient population (8 to 16 months) than the other authors and provided in-patient treatment. Generally, the muscles of the lower limb were stimulated, with treatment being given at home. Three studies varied the classic randomized controlled trial design: two by matching participants 1, 17 and one by the use of a crossover design. 19 Two level I NMES studies showed statistically significant improvements. 1, 16 The study by Hazlewood et al. 1 employed NMES treatment on the anterior tibial musculature for 1 hour daily for 35 days, evaluating the effectiveness of the treatment by gait analysis and measuring range of movement and muscle strength. Statistically significant improvements were noted in passive and active ankle range of movement and in muscle strength. The Park et al. study 16 was the only one to stimulate the abdominal and posterior back muscles. Again, statistically significant improvements were observed at the level of impairment (decreased kyphotic angle and Cobb's angle) and at the level of activity limitation (improved Gross Motor Function Measure sitting score). It is noteworthy that the most recent, and most internally valid, of the NMES studies failed to demonstrate any statistically or clinically significant improvements with treatment. 17 In this study the hip extensors were stimulated for 1 hour per day, 6 days per week for 8 weeks. Outcome measures included three-dimensional gait analysis, myometer measurement of muscle strength, goniometric measurement of passive range of movement, and the Gross Motor Function Measure. The power of this study was reduced by an inability to recruit adequate participant numbers as defined by their pre-study estimation of sample size.
Results

EMPIRICAL RESEARCH (LEVELS I AND II)
Only one of the three studies of TES supported its use, 18 The studies by Sommerfelt et al. 19 and Dali et al. 20 found no effect of TES after 1 year of treatment. The three TES studies employed similar stimulation parameters; however, two major differences existed between the TES studies that demonstrated no statistically significant change and the study by Steinbok et al. 18 Only one paper was classified as level III; 4 the remaining three studies presented level IV evidence. 21, 22, 23 Again, the studies varied in terms of participant characteristics and study design. Participant numbers were generally smaller than those of the level I studies, with Comeaux et al. 22 presenting the largest sample size of 14. Pape et al., 23 who reported the smallest cohort (n=6), also had one of the youngest groups studied, ranging in age from 37 to 58 months. The study by Atwater et al. 21 differed slightly from the others in that electromyography-triggered NMES was employed (i.e. the child was asked to contract the muscle and the EMG trace was recorded. NMES was activated when the child contracted their muscle to 40% of the recorded EMG trace). Various muscle groups were targeted, including the wrist extensors, 4,21 ankle dorsiflexors, 21 and lower limb musculature. 22, 23 The study by Comeaux et al. 22 failed to isolate the effects of electrical stimulation because participants also completed 15 minutes of gait activities daily.
The study by Pape et al. 23 demonstrated improvements in gross motor abilities during two phases of TES treatment (each lasting 6 months). These improvements were not maintained during a withdrawal phase. Although inconclusive findings were reported by Atwater et al. 21 on the use of NMES, Wright and Granat 4 described improvements in active wrist extension and hand function, and Comeaux et al. 22 reported improved dorsiflexion at heel strike.
NON-EMPIRICAL STUDIES (LEVEL V)
These studies are summarized in Table IV . Dubowitz 7 published the first report on the use of NMES for strengthening in children with CP. This was followed 2 years later by the first case report of TES with a patient with CP. 9 Only one other study described the use of TES, 2 in which a male aged 9 years underwent daytime and night-time electrical stimulation in an attempt to improve gait and functional abilities. Carmick documents the effects of task-orientated NMES with a series of children of different ages and types of CP, targeting both the upper and lower limbs. 3, 24, 25, 26 Carmick observed that the stimulation of spastic muscles in the upper 3 and the lower 26 case report by Bertoti et al. 27 differs from all the other reported applications of electrical stimulation in that the electrodes were sited intramuscularly. Stimulation was triggered either by the parent/therapist or by a switch inserted in the participant's shoe. Treatment ceased when clinically measurable gains were maintained without the use of stimulation. All the case reports described positive gains with the use of electrical stimulation: the most frequently reported were improvements in functional activities, 2, 3, 25, 26, 27 range of movement, 2, 24, 25, 26, 27 strength, 3, 7, 8, 26 and gait parameters. 2, 7, 9, 24, 26, 27 TREATMENT PARAMETERS Most authors employed similar parameters, as shown in Table V . Parameters were well defined by all except a few authors. 9, 20, 26 Frequencies were generally in the range 30 to 45Hz, pulse durations 100 to 300µs, and the time taken to reach the desired intensity (ramp up) ranged from 0.5 to 2 seconds. Some variation existed in the contraction/relaxation times for the activation of the muscles (on:off times). The TES on:off times were generally equal; however, with NMES some authors used equal times 3, 4 and others ensured that the 'off ' time was at least double the 'on' time. 1, 17, 27 The intensity of stimulation and duration of treatment depended on whether TES or NMES was employed, with TES tending to be applied for a minimum of 30 hours per week for 6 to 17 months. NMES was most commonly applied for 15 to 20 minutes per week in a task-orientated therapy setting, 3, 24, 25 or for up to 1 hour daily for 2 months when applied at home. 17 
OUTCOME MEASURES
The AACPDM framework also describes the level of evidence of a study in terms of the categories described by the International Classification of Functioning, Disability and Health (ICF). 28 The present review has not taken such an approach because it sought to discern the efficacy of an intervention as opposed to defining the level at which that intervention might or might not have taken effect. However, it is important to note that most of the electrical stimulation studies measured both impairment (indicating the problems in body structures or functions) and activity limitations (the difficulties that an individual might experience in the execution of a task). 28 It is noteworthy that none of the studies reviewed used a standardized healthrelated quality-of-life measure to determine whether the intervention under investigation reduced participation restrictions (the problems experienced in life situations) 28 or indeed whether compliance with the treatment protocol actually increased the participation restrictions experienced.
Discussion
Eighteen articles were identified for review in this paper. Of the 12 studies investigating the efficacy of NMES, one reported no improvement with treatment, 17 one reported inconclusive findings, 21 and the remaining 10 all described improvements in function and/or strength. In five of these studies statistical significance was reported. 1, 4, 16, 17, 22 It is noteworthy that the level I NMES studies 1, 16, 17 reported fewer positive outcomes than the uncontrolled studies and case reports.
Of the six TES studies, two reported statistically significant improvements, 18, 23 two reported no statistically significant effects, 19, 20 and the remaining two case reports described improvements. 2, 9 Interestingly, the level I/W TES studies that reported no statistically significant effects with electrical stimulation 19, 20 both documented a perceived positive effect of treatment as reported by parents/carers. It is also noteworthy that the participants in the study by Steinbok et al. 18 differed significantly from the participants of all the other studies in that they had previously undergone selective dorsal rhizotomy.
The scarcity of well-controlled trials makes it difficult to support definitively or discard the use of electrical stimulation in the paediatric CP population. The research is dominated by case studies and uncontrolled studies with small numbers of participants, which are thought to provide less powerful evidence than the criterion standard randomized controlled trial. 29, 30 Only Steinbok et al. 18 and van der Linden et al. 17 reported pre-study estimation of sample size and power analysis. Most studies recruited either children with hemiplegia or diplegia, effectively reducing their available participant numbers and the potential for generalization of results. Dali et al. 20 acknowledged recruiting participants with hemiplegia and those with diplegia to achieve a larger sample size, and van der Linden et al. 17 reported that it was impossible for them to recruit adequate numbers of participants. No other authors reported difficulties with recruitment or strategies for ensuring adequate sample size. Poor reporting, particularly in terms of randomization procedures, detail of the intervention, type of analysis, and interpretation and generalization of the results, was more common in the studies classified as levels III, IV and V. Many of the case studies advocated the use of electrical stimulation as a useful adjunct to established physiotherapy treatment 2, 9, 24, 25 but failed to acknowledge any potential biases in their work.
Difficulties arose when trying to compare studies owing to variations in stimulation parameters. Clarity in the reporting of stimulation parameters is essential because of their potential influence on study results and in facilitating replication and thus validation of study findings. No authors cited specific guidelines with regard to their choice of parameters. Existing guidelines differ on optimal settings, with Low and Reed 31 suggesting 50 to 100Hz for strengthening and Carmick 3 advocating 30 to 35Hz to ensure that sustained contraction is achieved. Interestingly, Balogun et al. 32 showed no significant difference in strength gains produced at 20, 45, and 80Hz in normal quadriceps musculature with the use of an NMES regimen.
Many of the studies would have benefited from the use of valid and reliable outcome measures. Improvements in strength and function were frequently documented, but the measurement tools and procedures used were not. This review has shown that it is necessary for therapists to use validated functional outcome measures when measuring functional change. However, accurate measurement of the components of functional tasks (e.g. range of movement and strength) is also invaluable because it can provide information on the causes of the problems experienced, and the mechanisms by which treatments might affect them. Quality of life, in terms of the impact of both the underlying condition and the proposed intervention on the child and family, should also be evaluated.
The issue of accurate measurement affects a key question when evaluating any treatment: how much change has to occur before it is considered clinically significant? Only Atwater et al. 21 and Steinbok et al. 18 defined clinical significance for their outcome measures. Several authors reported parent/carer perceptions of treatment effects that were not always supported by the study results. 4, 17, 19, 20 In conclusion it seems that there is more evidence to support the use of NMES than TES. However, the findings of the studies must be interpreted with caution because they generally had insufficient statistical power to provide conclusive evidence for or against these modalities. Further studies employing more rigorous study designs and follow-up, larger sample sizes, and homogeneous patient groups are required for the unequivocal support of the use of electrical stimulation. The age and type of patient most likely to benefit from this intervention and optimal treatment parameters are as yet unknown.
